CUCCHIARA, VITO
 Distribuzione geografica
Continente #
EU - Europa 1.385
NA - Nord America 1.080
AS - Asia 886
SA - Sud America 129
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 19
OC - Oceania 2
Totale 3.578
Nazione #
US - Stati Uniti d'America 1.028
RU - Federazione Russa 756
SG - Singapore 308
CN - Cina 276
IT - Italia 246
BR - Brasile 100
HK - Hong Kong 98
SE - Svezia 80
VN - Vietnam 80
DE - Germania 73
FR - Francia 47
FI - Finlandia 46
GB - Regno Unito 39
CA - Canada 31
IN - India 29
BD - Bangladesh 25
NL - Olanda 25
ES - Italia 16
MX - Messico 15
JP - Giappone 13
AR - Argentina 12
PL - Polonia 12
AT - Austria 9
PK - Pakistan 8
TR - Turchia 8
ZA - Sudafrica 8
BE - Belgio 6
EC - Ecuador 6
MY - Malesia 6
AE - Emirati Arabi Uniti 4
IQ - Iraq 4
LT - Lituania 4
NO - Norvegia 4
SA - Arabia Saudita 4
UA - Ucraina 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
GR - Grecia 3
IE - Irlanda 3
IL - Israele 3
PH - Filippine 3
AU - Australia 2
CO - Colombia 2
CR - Costa Rica 2
ID - Indonesia 2
KE - Kenya 2
MD - Moldavia 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
SN - Senegal 1
TC - Turks e Caicos 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
ZM - Zambia 1
Totale 3.501
Città #
Singapore 191
Dallas 183
Moscow 144
Ashburn 142
Hong Kong 96
San Jose 93
Milan 87
New York 77
Beijing 49
Shanghai 47
Los Angeles 38
Council Bluffs 36
Ho Chi Minh City 33
Santa Clara 31
Munich 30
Hefei 29
Lauterbourg 28
Turku 26
Orem 23
Boardman 20
Hanoi 17
Princeton 16
Lawrence 15
Rome 15
Helsinki 14
Chennai 13
Frankfurt am Main 13
Nuremberg 13
São Paulo 13
Montreal 12
London 10
Phoenix 9
Amsterdam 8
Brooklyn 8
Buffalo 8
Manchester 8
Warsaw 8
Bologna 7
Chicago 7
Denver 7
Stockholm 7
Ankara 6
Da Nang 6
Lappeenranta 6
Mexico City 6
Rho 6
San Diego 6
Seattle 6
Tokyo 6
Valencia 6
Cesano Boscone 5
Columbus 5
Johannesburg 5
San Francisco 5
The Dalles 5
Turin 5
Vienna 5
Atlanta 4
Bexley 4
Boston 4
Brussels 4
Houston 4
Kuala Lumpur 4
Macerata 4
Naples 4
Oslo 4
Poplar 4
Pune 4
Querétaro 4
Reston 4
Aci Sant'antonio 3
Athens 3
Barnet 3
Bauru 3
Birmingham 3
Brasília 3
Dublin 3
Falkenstein 3
Fortaleza 3
Guayaquil 3
L’Aquila 3
Manassas 3
Milwaukee 3
Mumbai 3
Novara 3
Omaha 3
Ottawa 3
Paderborn 3
Palermo 3
Romagnano Sesia 3
Tianjin 3
Toronto 3
Zhengzhou 3
Zurich 3
Abu Dhabi 2
Ancona 2
Aurora 2
Baie-D'Urfé 2
Belfast 2
Belo Horizonte 2
Totale 1.856
Nome #
IL RUOLO DELLE CELLULE T DI MEMORIA RESIDENTI NEI TESSUTI NEL TUMORE PROSTATICO: IMPLICAZIONI PER GLI ESITI ONCOLOGICI 249
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 178
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 168
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 163
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 163
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 152
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 146
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 130
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 129
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 127
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 127
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 125
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 124
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 124
Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 121
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 119
Supplementary Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 117
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 112
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 110
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 106
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 101
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 96
ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 95
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 92
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer 89
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 81
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond 81
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review 72
SINGLE NUCLEOTIDE POLYMORPHISMS AND RISK OF PROSTATE CANCER: DEVELOPMENT AND VALIDATION OF A NOVEL GENETIC RISK SCORE FOR INDIVIDUALIZED SCREENING AND DIAGNOSTIC PROGRAMMES 37
Diagnostic Accuracy of Fully Hybrid PET/MRI with [68 Ga]Ga-PSMA-11 and [68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard 36
SARS-CoV-2 genomic surveillance of migrants arriving to Europe through the Mediterranean routes 4
Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression 4
Totale 3.578
Categoria #
all - tutte 15.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 9 2 7 2 3 3 3 0 0 0 3
2022/2023143 39 28 11 13 4 15 5 12 4 3 2 7
2023/2024219 3 18 23 17 18 49 3 20 0 16 17 35
2024/2025697 48 26 32 25 49 50 115 95 83 42 63 69
2025/20262.340 159 141 162 270 200 76 195 202 648 140 66 81
2026/2027146 81 65 0 0 0 0 0 0 0 0 0 0
Totale 3.578